BSE in gelatin
Executive Summary
FDA Transmissible Spongiform Encephalopathies Advisory Committee will discuss results of a study on the inactivation of TSE agent by the manufacturing process for gelatin as one agenda item during June 28-29 meeting. The meeting will take place at the Holiday Inn in Bethesda, Md. and will begin at 8 a.m. both days